Literature DB >> 11160804

In vitro resistance of Burkholderia cepacia complex isolates to reactive oxygen species in relation to catalase and superoxide dismutase production.

M Lefebre1, M Valvano.   

Abstract

The Burkholderia cepacia complex comprises groups of genomovars (genotypically distinct strains with very similar phenotypes) that have emerged as important opportunistic pathogens in cystic fibrosis (CF) patients. The inflammatory response against bacteria in the airways of CF individuals is dominated by polymorphonuclear cells and involves the generation of oxidative stress, which leads to further inflammation and tissue damage. Bacterial catalase, catalase-peroxidase and superoxide dismutase activities may contribute to the survival of B. cepacia following exposure to reactive oxygen metabolites generated by host cells in response to infection. In the present study the authors investigated the production of catalase, peroxidase and SOD by isolates belonging to various genomovars of the B. cepacia complex. Production of both catalase and SOD was maximal during late stationary phase in almost all isolates examined. Native PAGE identified 13 catalase electrophoretotypes and two SOD electrophoretotypes (corresponding to an Fe-SOD class) in strains belonging to the six genomovars of the B. cepacia complex. Seven out of 11 strains displaying high-level survival after H(2)O(2) treatment in vitro had a bifunctional catalase/peroxidase, and included all the genomovar III strains examined. These isolates represent most of the epidemic isolates that are often associated with the cepacia syndrome. The majority of the isolates from all the genomovars were resistant to extracellular O(-)(2), while resistance to intracellularly generated O(-)(2)was highly variable and could not be correlated with the detected levels of SOD activity. Altogether the results suggest that resistance to toxic oxygen metabolites from extracellular sources may be a factor involved in the persistence of B. cepacia in the airways of CF individuals.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11160804     DOI: 10.1099/00221287-147-1-97

Source DB:  PubMed          Journal:  Microbiology        ISSN: 1350-0872            Impact factor:   2.777


  22 in total

Review 1.  A decade of Burkholderia cenocepacia virulence determinant research.

Authors:  Slade A Loutet; Miguel A Valvano
Journal:  Infect Immun       Date:  2010-07-19       Impact factor: 3.441

2.  Burkholderia cenocepacia creates an intramacrophage replication niche in zebrafish embryos, followed by bacterial dissemination and establishment of systemic infection.

Authors:  Annette C Vergunst; Annemarie H Meijer; Stephen A Renshaw; David O'Callaghan
Journal:  Infect Immun       Date:  2010-01-19       Impact factor: 3.441

3.  Immune Recognition of the Epidemic Cystic Fibrosis Pathogen Burkholderia dolosa.

Authors:  Damien Roux; Molly Weatherholt; Bradley Clark; Mihaela Gadjeva; Diane Renaud; David Scott; David Skurnik; Gregory P Priebe; Gerald Pier; Craig Gerard; Deborah R Yoder-Himes
Journal:  Infect Immun       Date:  2017-05-23       Impact factor: 3.441

4.  Reconstitution of O-specific lipopolysaccharide expression in Burkholderia cenocepacia strain J2315, which is associated with transmissible infections in patients with cystic fibrosis.

Authors:  Ximena Ortega; Tracey A Hunt; Slade Loutet; Arlene D Vinion-Dubiel; Anup Datta; Biswa Choudhury; Joanna B Goldberg; Russell Carlson; Miguel A Valvano
Journal:  J Bacteriol       Date:  2005-02       Impact factor: 3.490

5.  Differential persistence among genomovars of the Burkholderia cepacia complex in a murine model of pulmonary infection.

Authors:  Karen K Chu; Donald J Davidson; T Keith Halsey; Jacqueline W Chung; David P Speert
Journal:  Infect Immun       Date:  2002-05       Impact factor: 3.441

6.  Characterization of SodC, a periplasmic superoxide dismutase from Burkholderia cenocepacia.

Authors:  Karen E Keith; Miguel A Valvano
Journal:  Infect Immun       Date:  2007-02-26       Impact factor: 3.441

7.  Oxidative stress of Burkholderia cenocepacia induces insertion sequence-mediated genomic rearrangements that interfere with macrorestriction-based genotyping.

Authors:  Pavel Drevinek; Adam Baldwin; Laurens Lindenburg; Lovleen Tina Joshi; Angela Marchbank; Sarka Vosahlikova; Christopher G Dowson; Eshwar Mahenthiralingam
Journal:  J Clin Microbiol       Date:  2009-11-04       Impact factor: 5.948

8.  Phagocyte NADPH oxidase, but not inducible nitric oxide synthase, is essential for early control of Burkholderia cepacia and chromobacterium violaceum infection in mice.

Authors:  Brahm H Segal; Li Ding; Steven M Holland
Journal:  Infect Immun       Date:  2003-01       Impact factor: 3.441

9.  Identification of Burkholderia cenocepacia genes required for bacterial survival in vivo.

Authors:  Tracey A Hunt; Cora Kooi; Pamela A Sokol; Miguel A Valvano
Journal:  Infect Immun       Date:  2004-07       Impact factor: 3.441

10.  Burkholderia cenocepacia C5424 produces a pigment with antioxidant properties using a homogentisate intermediate.

Authors:  Karen E Keith; Lauren Killip; Panqing He; Graham R Moran; Miguel A Valvano
Journal:  J Bacteriol       Date:  2007-10-12       Impact factor: 3.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.